Skip to main content
Top
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Research article

Computer-assisted cognitive remediation therapy increases hippocampal volume in patients with schizophrenia: a randomized controlled trial

Authors: Tsubasa Morimoto, Yasuhiro Matsuda, Kiwamu Matsuoka, Fumihiko Yasuno, Emi Ikebuchi, Hiroyuki Kameda, Toshiaki Taoka, Toshiteru Miyasaka, Kimihiko Kichikawa, Toshifumi Kishimoto

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

Cognitive remediation therapy (CRT) effectively reduces neurocognitive impairment in patients with schizophrenia, but few studies have used structural neuroimaging methods to assess its neuroanatomical effects. We investigated these effects, as well as the association between changes in cortical volume and neurocognitive performance.

Method

Between August 2013 and September 2016, we performed a randomized controlled study comprising a CRT group (16 individuals) and a treatment-as-usual (TAU) group (15 individuals) of patients with schizophrenia. CRT participants engaged in twice-weekly computer-assisted CRT sessions and weekly group meetings for 12 weeks. T1-weighted magnetic resonance imaging was performed before and after the intervention period, and whole-brain voxel-based morphometric analysis was used to detect significant cortical gray matter volume changes. We also assessed the correlation between cortical volume changes and CRT-derived neurocognitive improvements.

Results

The CRT group exhibited significantly greater improvements than the TAU group in verbal fluency (P = 0.012) and global cognitive scores (P = 0.049). The CRT group also exhibited significantly greater increases in right hippocampal volume than the TAU group (P < 0.001). Changes in verbal fluency scores and right hippocampal volumes were positively correlated (r = 0.53, P = 0.001).

Conclusion

We found that CRT significantly increased right hippocampal volumes and that these enhancements were positively correlated with changes in verbal fluency scores. Our results indicate that CRT induces cognitive improvement through hippocampal plasticity.

Trial registration

Registration number: UMIN000026146, 2017/02/15, retrospectively registered.
Literature
1.
go back to reference Strauss JS, Carpenter WT Jr. The prognosis of schizophrenia: rationale for a multidimensional concept. Schizophr Bull 1978;4:56–67. Strauss JS, Carpenter WT Jr. The prognosis of schizophrenia: rationale for a multidimensional concept. Schizophr Bull 1978;4:56–67.
2.
go back to reference Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O’Leary DS, Ho BC, Andreasen NC, Lauriello J, Schulz SC. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res. 2010;44:421–8.CrossRefPubMed Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O’Leary DS, Ho BC, Andreasen NC, Lauriello J, Schulz SC. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res. 2010;44:421–8.CrossRefPubMed
3.
go back to reference Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical grey matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2:e190.CrossRefPubMedPubMedCentral Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical grey matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2:e190.CrossRefPubMedPubMedCentral
4.
go back to reference Harvey PD, Keefe RS. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry. 2001;158:176–84.CrossRefPubMed Harvey PD, Keefe RS. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry. 2001;158:176–84.CrossRefPubMed
5.
go back to reference Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007;164:1061–71.CrossRefPubMed Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007;164:1061–71.CrossRefPubMed
6.
go back to reference Sato S, Iwata K, Furukawa SI, Matsuda Y, Hatsuse N, Ikebuchi E. The effects of the combination of cognitive training and supported employment on improving clinical and working outcomes for people with schizophrenia in Japan. Clin Pract Epidemiol Ment Health. 2013;10:18–27.CrossRefPubMed Sato S, Iwata K, Furukawa SI, Matsuda Y, Hatsuse N, Ikebuchi E. The effects of the combination of cognitive training and supported employment on improving clinical and working outcomes for people with schizophrenia in Japan. Clin Pract Epidemiol Ment Health. 2013;10:18–27.CrossRefPubMed
7.
go back to reference McGurk SR, Mueser KT, Xie H, Welsh J, Kaiser S, Drake RE, Becker DR, Bailey E, Fraser G, Wolfe R, et al. Cognitive enhancement treatment for people with mental illness who do not respond to supported employment: a randomized controlled trial. Am J Psychiatry. 2015;172:852–61.CrossRefPubMed McGurk SR, Mueser KT, Xie H, Welsh J, Kaiser S, Drake RE, Becker DR, Bailey E, Fraser G, Wolfe R, et al. Cognitive enhancement treatment for people with mental illness who do not respond to supported employment: a randomized controlled trial. Am J Psychiatry. 2015;172:852–61.CrossRefPubMed
8.
9.
go back to reference McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:1791–802.CrossRefPubMedPubMedCentral McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:1791–802.CrossRefPubMedPubMedCentral
10.
go back to reference Chan JY, Hirai HW, Tsoi KK. Can computer-assisted cognitive remediation improve employment and productivity outcomes of patients with severe mental illness? A meta-analysis of prospective controlled trials. J Psychiatr Res. 2015;68:293–300.CrossRefPubMed Chan JY, Hirai HW, Tsoi KK. Can computer-assisted cognitive remediation improve employment and productivity outcomes of patients with severe mental illness? A meta-analysis of prospective controlled trials. J Psychiatr Res. 2015;68:293–300.CrossRefPubMed
11.
go back to reference Matsuda Y, Morimoto T, Furukawa S, Sato S, Hatsuse N, Iwata K, Kimura M, Kishimoto T, Ikebuchi E. Feasibility and effectiveness of a cognitive remediation programme with original computerised cognitive training and group intervention for schizophrenia: a multicentre randomised trial. Neuropsychol Rehabil. 2016;6:1–11. Matsuda Y, Morimoto T, Furukawa S, Sato S, Hatsuse N, Iwata K, Kimura M, Kishimoto T, Ikebuchi E. Feasibility and effectiveness of a cognitive remediation programme with original computerised cognitive training and group intervention for schizophrenia: a multicentre randomised trial. Neuropsychol Rehabil. 2016;6:1–11.
12.
go back to reference Penadés R, Pujol N, Catalán R, Massana G, Rametti G, García-Rizo C, Bargalló N, Gastó C, Bernardo M, Junqué C. Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 2013;73:1015–23.CrossRefPubMed Penadés R, Pujol N, Catalán R, Massana G, Rametti G, García-Rizo C, Bargalló N, Gastó C, Bernardo M, Junqué C. Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 2013;73:1015–23.CrossRefPubMed
13.
go back to reference Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS. Neuroprotective effects of cognitive enhancement therapy against grey matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010;67:674–82.CrossRefPubMedPubMedCentral Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS. Neuroprotective effects of cognitive enhancement therapy against grey matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010;67:674–82.CrossRefPubMedPubMedCentral
14.
go back to reference Pohlack ST, Meyer P, Cacciaglia R, Liebscher C, Ridder S, Flor H. Bigger is better! Hippocampal volume and declarative memory performance in healthy young men. Brain Struct Funct. 2014;219:255–67.CrossRefPubMed Pohlack ST, Meyer P, Cacciaglia R, Liebscher C, Ridder S, Flor H. Bigger is better! Hippocampal volume and declarative memory performance in healthy young men. Brain Struct Funct. 2014;219:255–67.CrossRefPubMed
15.
go back to reference Koch K, Reess TJ, Rus OG, Zimmer C. Extensive learning is associated with grey matter changes in the right hippocampus. NeuroImage. 2016;125:627–32.CrossRefPubMed Koch K, Reess TJ, Rus OG, Zimmer C. Extensive learning is associated with grey matter changes in the right hippocampus. NeuroImage. 2016;125:627–32.CrossRefPubMed
16.
go back to reference Kühn S, Gleich T, Lorenz RC, Lindenberger U, Gallinat J. Playing super Mario induces structural brain plasticity: grey matter changes resulting from training with a commercial video game. Mol Psychiatry. 2013;19:265–71.CrossRefPubMed Kühn S, Gleich T, Lorenz RC, Lindenberger U, Gallinat J. Playing super Mario induces structural brain plasticity: grey matter changes resulting from training with a commercial video game. Mol Psychiatry. 2013;19:265–71.CrossRefPubMed
17.
go back to reference Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A. 2007;104:5638–43.CrossRefPubMedPubMedCentral Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A. 2007;104:5638–43.CrossRefPubMedPubMedCentral
18.
go back to reference Maass A, Düzel S, Goerke M, Becke A, Sobieray U, Neumann K, Lövdén M, Lindenberger U, Bäckman L, Braun-Dullaeus R, et al. Vascular hippocampal plasticity after aerobic exercise in older adults. Mol Psychiatry. 2015;20:585–93.CrossRefPubMed Maass A, Düzel S, Goerke M, Becke A, Sobieray U, Neumann K, Lövdén M, Lindenberger U, Bäckman L, Braun-Dullaeus R, et al. Vascular hippocampal plasticity after aerobic exercise in older adults. Mol Psychiatry. 2015;20:585–93.CrossRefPubMed
19.
go back to reference Kay SR, Fiszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.CrossRefPubMed Kay SR, Fiszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.CrossRefPubMed
20.
go back to reference Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci. 2007;61:602–9.CrossRefPubMed Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci. 2007;61:602–9.CrossRefPubMed
21.
go back to reference Kaneda Y, Sumiyoshi T, Nakagome K, Ikezawa S, Ohmori T, Noboru Y. Evaluation of cognitive functions in a normal population in Japan using the brief assessment of cognition in schizophrenia Japanese version (BACS-J) [in Japanese]. Seishin Igaku. 2013;55:167–75. Kaneda Y, Sumiyoshi T, Nakagome K, Ikezawa S, Ohmori T, Noboru Y. Evaluation of cognitive functions in a normal population in Japan using the brief assessment of cognition in schizophrenia Japanese version (BACS-J) [in Japanese]. Seishin Igaku. 2013;55:167–75.
22.
go back to reference Iwasaki S, Miyauchi M, Oshima I, Murata N, Nonaka T, Kato H, Ueno Y, Fujii K. Development of the life assessment scale for the mentally ill: a reliability assessment [in Japanese]. Seishin Igaku. 1994;36:1139–51. Iwasaki S, Miyauchi M, Oshima I, Murata N, Nonaka T, Kato H, Ueno Y, Fujii K. Development of the life assessment scale for the mentally ill: a reliability assessment [in Japanese]. Seishin Igaku. 1994;36:1139–51.
23.
25.
go back to reference Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry. 2009;66:549–53.CrossRefPubMedPubMedCentral Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry. 2009;66:549–53.CrossRefPubMedPubMedCentral
26.
go back to reference von Bohlen HO. Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci. 2010;2:36. von Bohlen HO. Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci. 2010;2:36.
27.
go back to reference Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM. BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience. 2002;114:795–805.CrossRefPubMed Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM. BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience. 2002;114:795–805.CrossRefPubMed
28.
go back to reference Alonso M, Medina JH, Pozzo-Miller L. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem. 2004;11:172–8.CrossRefPubMedPubMedCentral Alonso M, Medina JH, Pozzo-Miller L. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem. 2004;11:172–8.CrossRefPubMedPubMedCentral
29.
go back to reference Miyajima M, Omiya H, Yamashita K, Miyata T, Yambe K, Matsui M, Denda K. The effects of cognitive remediation therapy using the frontal/executive program for autism spectrum disorder. Int J Psychiatry Med. 2016;51:223–35.CrossRefPubMed Miyajima M, Omiya H, Yamashita K, Miyata T, Yambe K, Matsui M, Denda K. The effects of cognitive remediation therapy using the frontal/executive program for autism spectrum disorder. Int J Psychiatry Med. 2016;51:223–35.CrossRefPubMed
30.
go back to reference Pihlajamaki M, Tanila H, Hanninen T, Kononen M, Laakso MP, Partanen K, Soininen H, Aronen HJ. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol. 2000;47:470–6.CrossRefPubMed Pihlajamaki M, Tanila H, Hanninen T, Kononen M, Laakso MP, Partanen K, Soininen H, Aronen HJ. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol. 2000;47:470–6.CrossRefPubMed
31.
go back to reference Birchwood M, Patrick M, Jackson H. Early intervention in schizophrenia. Br J Psychiatry. 1997;170:2–5.CrossRefPubMed Birchwood M, Patrick M, Jackson H. Early intervention in schizophrenia. Br J Psychiatry. 1997;170:2–5.CrossRefPubMed
32.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;114:175–91.CrossRef Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;114:175–91.CrossRef
33.
go back to reference Okugawa G, Nobuhara K, Takase K, Saito Y, Yoshimura M, Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology. 2007;55:43–6.CrossRefPubMed Okugawa G, Nobuhara K, Takase K, Saito Y, Yoshimura M, Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology. 2007;55:43–6.CrossRefPubMed
Metadata
Title
Computer-assisted cognitive remediation therapy increases hippocampal volume in patients with schizophrenia: a randomized controlled trial
Authors
Tsubasa Morimoto
Yasuhiro Matsuda
Kiwamu Matsuoka
Fumihiko Yasuno
Emi Ikebuchi
Hiroyuki Kameda
Toshiaki Taoka
Toshiteru Miyasaka
Kimihiko Kichikawa
Toshifumi Kishimoto
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1667-1

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue